The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.

Suppr

超能文献

作者信息

Yoshimoto Eiichiro, Konishi Mitsuru, Takahashi Ken, Murakawa Koichi, Maeda Koichi, Mikasa Keiichi, Yamashina Yukio

机构信息

The Center for Infectious Diseases, Nara Medical University, Kashihara.

出版信息

Intern Med. 2004 Jul;43(7):630-1. doi: 10.2169/internalmedicine.43.630.

DOI:10.2169/internalmedicine.43.630

PMID:15335197

Abstract

摘要

相似文献

The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.

Intern Med. 2004 Jul;43(7):630-1. doi: 10.2169/internalmedicine.43.630.

Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.

Intern Med. 2004 Jul;43(7):533. doi: 10.2169/internalmedicine.43.533.

Photodermatitis in a patient with HIV infection.

J Am Acad Dermatol. 2003 Jul;49(1):159-60. doi: 10.1016/s0190-9622(03)70102-9.

Efavirenz-induced photoallergic dermatitis in HIV.

AIDS. 2001 May 25;15(8):1085-6. doi: 10.1097/00002030-200105250-00029.

Efavirenz-induced leukocytoclastic vasculitis.

Arch Intern Med. 2002 Feb 11;162(3):355-6. doi: 10.1001/archinte.162.3.355-a.

Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.

Jpn J Infect Dis. 2001 Dec;54(6):246-7.

Use of amitriptyline to offset sleep disturbances caused by efavirenz.

AIDS Patient Care STDS. 2005 Jul;19(7):419-20. doi: 10.1089/apc.2005.19.419.

Periconceptional exposure to efavirenz and neural tube defects.

Arch Intern Med. 2002 Feb 11;162(3):355. doi: 10.1001/archinte.162.3.355.

Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?

AIDS. 2000 Jul 28;14(11):1672-3. doi: 10.1097/00002030-200007280-00032.

Photosensitivity reaction of efavirenz.

Sex Transm Infect. 2000 Jun;76(3):221. doi: 10.1136/sti.76.3.221.

引用本文的文献

Prevalence of self reported photosensitivity and sunscreen use among people living with HIV in Thailand.

Sci Rep. 2025 Aug 27;15(1):31583. doi: 10.1038/s41598-025-12665-5.

Drug-Induced Photosensitivity-From Light and Chemistry to Biological Reactions and Clinical Symptoms.

Pharmaceuticals (Basel). 2021 Jul 26;14(8):723. doi: 10.3390/ph14080723.

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Photosensitive disorders in HIV.

South Afr J HIV Med. 2017 Aug 31;18(1):676. doi: 10.4102/sajhivmed.v18i1.676. eCollection 2017.

Antiviral drug allergy.

Immunol Allergy Clin North Am. 2014 Aug;34(3):645-62, ix. doi: 10.1016/j.iac.2014.04.011.

Efavirenz induces autophagy and aberrant differentiation in normal human keratinocytes.

Int J Mol Med. 2013 Jun;31(6):1305-12. doi: 10.3892/ijmm.2013.1327. Epub 2013 Apr 3.

HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.

J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. doi: 10.1093/jnci/djs529. Epub 2013 Jan 4.

Histological effects of chronic administration of efavirenz on lateral geniculate body of adult Wistar rats.

N Am J Med Sci. 2010 Jan;2(1):1-4. doi: 10.4297/najms.2010.11.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection.

Intern Med. 2004 Jul;43(7):630-1. doi: 10.2169/internalmedicine.43.630.

Photosensitive drug eruption induced by efavirenz in a patient with HIV infection.

Intern Med. 2004 Jul;43(7):533. doi: 10.2169/internalmedicine.43.533.

Photodermatitis in a patient with HIV infection.

J Am Acad Dermatol. 2003 Jul;49(1):159-60. doi: 10.1016/s0190-9622(03)70102-9.

Efavirenz-induced photoallergic dermatitis in HIV.

AIDS. 2001 May 25;15(8):1085-6. doi: 10.1097/00002030-200105250-00029.

Efavirenz-induced leukocytoclastic vasculitis.

Arch Intern Med. 2002 Feb 11;162(3):355-6. doi: 10.1001/archinte.162.3.355-a.

Skin eruption 8 days after a single dose of efavirenz-containing combination therapy.

Jpn J Infect Dis. 2001 Dec;54(6):246-7.

Use of amitriptyline to offset sleep disturbances caused by efavirenz.

AIDS Patient Care STDS. 2005 Jul;19(7):419-20. doi: 10.1089/apc.2005.19.419.

Periconceptional exposure to efavirenz and neural tube defects.

Arch Intern Med. 2002 Feb 11;162(3):355. doi: 10.1001/archinte.162.3.355.

Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?

AIDS. 2000 Jul 28;14(11):1672-3. doi: 10.1097/00002030-200007280-00032.

Photosensitivity reaction of efavirenz.

Sex Transm Infect. 2000 Jun;76(3):221. doi: 10.1136/sti.76.3.221.

引用本文的文献

Prevalence of self reported photosensitivity and sunscreen use among people living with HIV in Thailand.

Sci Rep. 2025 Aug 27;15(1):31583. doi: 10.1038/s41598-025-12665-5.

Drug-Induced Photosensitivity-From Light and Chemistry to Biological Reactions and Clinical Symptoms.

Pharmaceuticals (Basel). 2021 Jul 26;14(8):723. doi: 10.3390/ph14080723.

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5.

Photosensitive disorders in HIV.

South Afr J HIV Med. 2017 Aug 31;18(1):676. doi: 10.4102/sajhivmed.v18i1.676. eCollection 2017.

Antiviral drug allergy.

Immunol Allergy Clin North Am. 2014 Aug;34(3):645-62, ix. doi: 10.1016/j.iac.2014.04.011.

Efavirenz induces autophagy and aberrant differentiation in normal human keratinocytes.

Int J Mol Med. 2013 Jun;31(6):1305-12. doi: 10.3892/ijmm.2013.1327. Epub 2013 Apr 3.

HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer.

J Natl Cancer Inst. 2013 Mar 6;105(5):350-60. doi: 10.1093/jnci/djs529. Epub 2013 Jan 4.

Histological effects of chronic administration of efavirenz on lateral geniculate body of adult Wistar rats.

N Am J Med Sci. 2010 Jan;2(1):1-4. doi: 10.4297/najms.2010.11.

Drug-induced photosensitivity: culprit drugs, management and prevention.

Drug Saf. 2011 Oct 1;34(10):821-37. doi: 10.2165/11592780-000000000-00000.